Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed in an allergen challenge chamber
Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.5414/cp202389
Authors: Robert D. Murdoch, Philippe Bareille, Diane Ignar, Stephen Mark, Sam R. Miller, Ashutosh Gupta, Anne-Marie Salapatek, Piyush Patel
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2473809525
